1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Multiple active RFAs listed: RFA-DK-26-009 and RFA-DK-26-007 with deadlines June 26, 2025 or March 6, 2026. Stored deadline was null.
Special Diabetes Program (administered by NIDDK) is sponsored by National Institutes of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The Special Diabetes Program (SDP) is a federally funded program that provides annual funding to the National Institutes of Health (NIH) for type 1 diabetes (T1D) research, focusing on prevention, cure, management, and reduction of complications.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The information provided on niddk. nih. gov is not being updated.
Please refer to nih. gov. A **. gov** website belongs to an official government organization in the United States.
Research & FundingExpand Research & Funding Research Programs & Contacts Research Training & Career Development Funded Grants & Grant History Technology Advancement & Transfer Health InformationExpand Health Information La información de la salud en español Diabetes Discoveries & Practice Blog Community Health & Outreach Budget & Legislative Information Advisory & Coordinating Committees 5.
Type 1 Diabetes Special Statutory Funding Program Type 1 Diabetes Special Statutory Funding Program * Clinical Trials Recruiting Patients & Families * Consortia, Networks & Centers | **Posted Date**January 22, 2025 | **Title**New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) | **Open Date (Earliest Submission Date)**May 26, 2025 | **Application Due Date**June 26, 2025 or March 6, 2026 | **Full Announcement**RFA-DK-26-009_NIH external link_ | | **Posted Date**January 15, 2025 | **Title**Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed) | **Open Date (Earliest Submission Date)**May 26, 2025 | **Application Due Date**June 26, 2025 or March 6, 2026 | **Full Announcement**RFA-DK-26-007_NIH external link_ | Last Reviewed August 2024 NIH… Turning Discovery Into Health ® * Freedom of Information Act * U.S. Department of Health and Human Services * National Institutes of Health
According to the current listing, eligibility includes: Researchers and institutions focused on Type 1 diabetes research; specific eligibility varies per individual RFA announcement. Confirm the full requirements in the official notice before applying.
The current listing shows $160 million annually (program total); individual grant amounts vary per RFA. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 26, 2025, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Special Diabetes Program (administered by NIDDK) is funded by National Institutes of Health (NIH) / National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article